T Timonen
Overview
Explore the profile of T Timonen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
118
Citations
1725
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Inhibition of human NK cell function by valinomycin, a toxin from Streptomyces griseus in indoor air
Paananen A, Mikkola R, Sareneva T, Matikainen S, Andersson M, Julkunen I, et al.
Infect Immun
. 1999 Dec;
68(1):165-9.
PMID: 10603383
Streptomyces griseus strains isolated from indoor dust have been shown to synthesize valinomycin. In this report, we show that human peripheral blood lymphocytes treated with small doses (30 ng ml(-1))...
12.
Klefstrom J, Kovanen P, Somersalo K, Hueber A, Littlewood T, Evan G, et al.
Oncogene
. 1999 May;
18(13):2181-8.
PMID: 10327064
The contact of natural killer (NK) cells with foreign cells and with certain virus-infected or tumor cells triggers the cytolytic machinery of NK cells. This triggering leads to exocytosis of...
13.
Liede K, Hietanen J, SAXEN L, Haukka J, Timonen T, Hayrinen-Immonen R, et al.
Oral Dis
. 1998 Jul;
4(2):78-83.
PMID: 9680894
Objective: To assess the effect of alpha-tocopherol and beta-carotene supplementation on the prevalence of oral mucosal lesions in smokers. Design: An end-point examination of a random sample of participants in...
14.
Elonen E, Almqvist A, Hanninen A, Jansson S, JARVENTIE G, Koistinen P, et al.
Leukemia
. 1998 Jul;
12(7):1041-8.
PMID: 9665188
In acute myelogenous leukemia (AML) intensive postremission treatment is needed for an optimal result. However, it is not known how long the treatment should last and how many courses are...
15.
Helander T, Timonen T
Curr Top Microbiol Immunol
. 1998 May;
230:89-99.
PMID: 9586352
No abstract available.
16.
Kekomaki S, Volin L, Koistinen P, Koivunen E, Koskimies S, Ruutu T, et al.
Eur J Haematol
. 1998 Mar;
60(2):112-8.
PMID: 9508352
Six patients, 4 with acute myeloid leukaemia and 2 with a myelodysplastic syndrome who were refractory to random donor platelet transfusions and alloimmunized to human leucocyte antigens (HLA) and human...
17.
Timonen T
J Leukoc Biol
. 1997 Dec;
62(6):693-701.
PMID: 9400809
Natural killer (NK) cells form a unique third group of lymphocytes that differs from T and B cells in surface phenotype, target recognition, and function. By producing cytokines and exerting...
18.
Timonen T, Helander T
Curr Opin Cell Biol
. 1997 Oct;
9(5):667-73.
PMID: 9330870
Research into the molecular mechanisms of target cell recognition by natural killer (NK) cells has recently progressed rapidly. NK cells express several MHC I recognizing receptors that inactivate the NK...
19.
Vaheri A, Carpen O, Heiska L, Helander T, Jaaskelainen J, Sainio M, et al.
Curr Opin Cell Biol
. 1997 Oct;
9(5):659-66.
PMID: 9330869
Ezrin, radixin, moesin and merlin form a subfamily of conserved proteins in the band 4.1 superfamily. Ezrin protein subfamily members act as linkers between the plasma membrane and the cytoskeleton....
20.
Maenpaa A, Kovanen P, Paetau A, Jaaskelainen J, Timonen T
Acta Neuropathol
. 1997 Sep;
94(3):216-25.
PMID: 9292690
To identify antigenic differences between gliomas and normal brain, we have immunohistochemically studied the expression of lymphocyte adhesion molecules (ICAM-1, ICAM-2, ICAM-3, VCAM-1, E-selectin and CD58), epidermal growth factor receptor...